Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000339634 | SCV000341239 | uncertain significance | not provided | 2016-04-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765662 | SCV000896996 | uncertain significance | Vanishing white matter disease | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Kasturba Medical College, |
RCV000765662 | SCV001479314 | uncertain significance | Vanishing white matter disease | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000339634 | SCV002271358 | likely pathogenic | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects EIF2B4 function (PMID: 27812215). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 287459). This variant is also known as p.R467W or p.R487W. This missense change has been observed in individual(s) with EIF2B4-related conditions (PMID: 18263758, 32180488, 34745209; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs138249238, gnomAD 0.02%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 466 of the EIF2B4 protein (p.Arg466Trp). |
3billion | RCV000765662 | SCV003841530 | likely pathogenic | Vanishing white matter disease | 2023-02-23 | criteria provided, single submitter | clinical testing | This homozygous variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.003%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.84; 3Cnet: 0.47). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with EIF2B4-related disorder (PMID: 18263758). A different missense change at the same codon (p.Arg467Gln) has been reported to be associated with EIF2B4-related disorder (PMID: 32962729). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |